Filing Details

Accession Number:
0001209191-16-142357
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-21 21:29:54
Reporting Period:
2016-09-19
Filing Date:
2016-09-21
Accepted Time:
2016-09-21 21:29:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
873303 Sarepta Therapeutics Inc. SRPT Pharmaceutical Preparations (2834) 930797222
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522780 Md M. Edward Kaye 215 First Street
Suite 415
Cambridge MA 02142
President, Ceo & Cmo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-09-19 13,000 $8.28 89,983 No 4 M Direct
Common Stock Disposition 2016-09-19 13,000 $50.00 76,983 No 4 S Direct
Common Stock Acquisiton 2016-09-19 947 $5.40 77,930 No 4 M Direct
Common Stock Disposition 2016-09-19 947 $50.00 76,983 No 4 S Direct
Common Stock Acquisiton 2016-09-19 10,405 $5.40 87,388 No 4 M Direct
Common Stock Disposition 2016-09-19 10,405 $50.00 76,983 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options (right to buy) Disposition 2016-09-19 13,000 $8.28 13,000 $13.90
Common Stock Incentive Stock Options (right to buy) Disposition 2016-09-19 947 $5.40 947 $5.40
Common Stock Non-Qualified Stock Options (right to buy) Disposition 2016-09-19 10,405 $5.40 10,405 $5.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
80,358 2012-06-20 2012-06-20 No 4 M Direct
0 2013-04-24 2022-04-24 No 4 M Direct
0 2013-04-24 2022-04-24 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.